NCT05454007

Brief Summary

The purpose of this proposal is to use novel video-based movement tracking technology to measure gait quality after stroke - in the home. Current rehabilitation practice assesses walking in the highly controlled 'ideal' clinical environment. The implicit assumption by clinicians and researchers is that the way people walk in the clinic (their best capacity) reflects the way they walk in the real-world (true performance). With advances in computer vision and development of pose estimation algorithms, it is now possible to directly measure how people are walking in their homes. It is critical that researchers apply this technology to examine the basic assumptions that underlie current rehabilitation practice. Here, a video-based pose estimation workflow will be used to 1) contrast the gait patterns of persons post-stroke as observed in-clinical vs. in-home settings, and 2) map the rate of deterioration of clinically-derived walking improvements, in the home. This methodology has been used to accurately measure gait kinematics in people with stroke as they walk in laboratory, however this study now seeks to use these methods to record people with stroke as they walk in their natural home environments. The ultimate outcome of this project will not only be freely-available video-based workflow modified for home-based gait assessments, but also preliminary data revealing how people with stroke walk in the real world.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 12, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

August 25, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2025

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

July 24, 2026

Completed
Last Updated

July 24, 2026

Status Verified

June 1, 2026

Enrollment Period

2.5 years

First QC Date

June 21, 2022

Results QC Date

April 20, 2026

Last Update Submit

June 26, 2026

Conditions

Keywords

gaitstep length asymmetrywalking

Outcome Measures

Primary Outcomes (4)

  • Step Length Asymmetry

    The normalized difference between short step length and long step length; a spatial parameter absolute value of (left step length - right step length) / left step length + right step length Will be compared across timepoints.

    In-clinic baseline (day 1), in-home baseline (day 1)

  • Step Time Symmetry

    The normalized difference between short step time and long step time; a temporal parameter (absolute value(left step time- right step time))/(left step time + right step time) Will be compared across timepoints.

    In-clinic baseline (day 1), in-home baseline (day 1)

  • Self Selected Gait Speed

    The speed at which a participant is walking (meters/second) Will be compared across timepoints.

    In-clinic baseline (day 1), in-home baseline (day 1)

  • Step Length Asymmetry (Transfer)

    The normalized difference between short step length and long step length; a spatial parameter absolute value of (left step length - right step length) / left step length + right step length

    Aim 2: clinic before training, clinic after training, same day transfer, 1-day transfer, 3-day transfer, 1-week transfer

Other Outcomes (2)

  • Depression Via PHQ-9

    Measured once, during the first session which takes place on a single day.

  • Berg Balance Scale

    Measured once, during the first session which takes place on a single day.

Study Arms (2)

Individuals with Stroke

EXPERIMENTAL

Individuals with stroke who meet inclusion and exclusion criteria were included in Aim 1 and Aim 2 of the study. In aim 1, they engaged in a standard neurological screen and participated in clinic- and home-based walking trials. In Aim 2, they underwent a single session of step length symmetry training and submitted a series of home walking videos to track how durable improvements were from the clinic to home.

Behavioral: Step length asymmetry training

Neurologically Intact Adults

NO INTERVENTION

Healthy Adults/Adults without Stroke participated in Aim 1, but not Aim 2 of the study. They underwent the same screening and neurological assessment as participants with stroke and performed clinic-based and home-based walking trials. They did not receive intervention.

Interventions

For aim 2, participants with stroke engaged in five, two-minute periods of step symmetry training during session 2. This training uses established sensorimotor adaptation-based methods (e.g. split-belt treadmill walking, walking with unilateral leg weighting) to elicit motor aftereffects of more equal step lengths. Two minute sitting rest breaks will be given between training blocks or at the participant's request. A video recording will be taken of the first and final period of training.

Individuals with Stroke

Eligibility Criteria

Age21 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stroke \>6 months prior
  • hemiparetic gait pattern with step length difference of 2cm or greater
  • able to ambulate whiteout physical assistance from another person (use of an assistive device are acceptable), gait speed \>/= 0.2m/s
  • normal or corrected-to-normal vision

You may not qualify if:

  • neurological condition other than stroke
  • aphasia limiting comprehension of task instructions pregnancy
  • uncontrolled hypertension (\> 150/90 mmHg at rest)
  • dementia, cognitive impairments, or psychiatric disorders limiting the ability to provide informed consent
  • epilepsy
  • orthopedic or pain conditions limiting walking
  • concurrent engagement in physical therapy or other research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Western University of Health Sciences

Lebanon, Oregon, 97355, United States

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Dr. Kendra Cherry-Allen, PhD, PT, DPT
Organization
Western University of Health Sciences

Study Officials

  • Kendra Cherry-Allen, PhD, PT, DPT

    Western University of Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Aim 1, which is a direct comparison of how people walk in the clinic and in the home, will include both adults with stroke and neurologically intact adults. Aim 2 which assesses the durability of step symmetry improvements in the real world, will only involve the participants with stroke.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 21, 2022

First Posted

July 12, 2022

Study Start

August 25, 2022

Primary Completion

March 9, 2025

Study Completion

March 9, 2025

Last Updated

July 24, 2026

Results First Posted

July 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

De-identified data will be curated and deposited to appropriate public repositories whenever applicable. All behavioral data will be made available per reasonable request to the PI and all software will be made available on our GitHub archive.

Shared Documents
ANALYTIC CODE
Time Frame
Software will be posted to GitHub repository upon the conclusion of the study and will remain open access and freely available indefinitely.
Access Criteria
De-identified data will be curated and deposited to appropriate public repositories whenever applicable. All behavioral data will be made available per reasonable request to the PI and all software will be made available on our GitHub archive.

Locations